Show Summary Details
Page of

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death 

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

Hamilton Hicks

, and Cenk Tek

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 11 August 2020

This chapter provides a summary of a landmark study on schizophrenia. The study authors sought to compare the safety of typical and atypical antipsychotics with regard to a fatal adverse event. Are atypical antipsychotic drugs associated with a lower risk of sudden cardiac death compared to typical antipsychotics? Starting with that question, this chapter describes the basics of the study, including the funding source, study location, who was studied, how many patients, study design, study intervention, follow-up, study endpoints, results, as well as criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.